CAS 229476-53-3

4-Quinazolinamine, N-(3-bromophenyl)-6,7-dimethoxy-N-methyl-

CAS : 229476-53-3

Formule : C₁₇H₁₆BrN₃O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 374.2318

Ref: IN-DA002LMH

EBE-A22

CAS : 229476-53-3

EBE-A22

Degré de pureté : ≥98%

Masse moléculaire : 374.23g/mol

Ref: 54-BUP09914

EBE-A22

CAS : 229476-53-3

EBE-A22 (PD153035 Analog 63) is a derivative of PD 153035 which can inhibit ErbB-1-phosphorylation, whereas EBE-A22 is inactive.

Formule : C₁₇H₁₆BrN₃O₂

Degré de pureté : 99.087% - 99.88%

Couleur et forme : Solid

Masse moléculaire : 374.23

Ref: TM-T3558

EBE-A 22

CAS : 229476-53-3

EBE-A 22 is a tyrosine kinase inhibitor that binds to the ATP-binding site of the enzyme and prevents it from transferring phosphate groups. It is orally active and has been shown to inhibit tumor growth in mice with Ewing sarcoma, myeloma cell lines, and squamous carcinomas. EBE-A 22 has also been shown to inhibit tyrosine kinase activity, leading to decreased proliferation of various cells and inhibition of ribosome synthesis. This drug also inhibits receptor activity by binding to the ATP-binding site on the receptor, preventing it from eliciting a cellular response.

Formule : C₁₇H₁₆BrN₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 374.23 g/mol

Ref: 3D-EJA47653